Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors

Liu, Y., Mullangi, S., Debono, D., Chen, X., Pham, T., Fisch, M. J., Gordon, A. S., & Hershman, D. L. (2023). Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors. JCO Oncology Practice, 19(9), 731–740. https://doi.org/10.1200/op.23.00199
Authors:
Ying Liu
Samyukta Mullangi
David Debono
Xiaoxue Chen
Timothy Pham
Michael J Fisch
Aliza S Gordon
Dawn L Hershman
Affiliated Authors:
Dawn L Hershman
Subjects:
Melanoma (MeSH)
Publication Type:
Article
Unique ID:
10.1200/op.23.00199
PMID:
Publication Date:
Data Source:
PubMed

Record Created: